Contents

Valve SurgeryEdit

Valve surgery refers to interventions aimed at repairing or replacing diseased heart valves to restore normal blood flow and improve cardiac function. The heart’s mitral, aortic, tricuspid, and pulmonary valves regulate the one-way movement of blood between chambers and into the great vessels. When these valves become stiff, leaky, or otherwise dysfunctional, patients may experience symptoms such as shortness of breath, fatigue, chest pain, or fainting, and long-term consequences can include heart failure or diminished quality of life. Treatment decisions balance the goals of durable relief from symptoms and preservation of heart function with the risks of surgery or percutaneous procedures.

Advances in valve surgery have expanded the toolbox for managing valve disease. Traditional open-heart surgery using cardiopulmonary bypass remains a cornerstone, especially for certain patients and valve conditions. In recent decades, less invasive approaches—most notably transcatheter techniques—have broadened options for those deemed high risk for conventional surgery or seeking alternatives with shorter recovery times. Across these modalities, surgeons and cardiologists emphasize careful patient selection, high-quality imaging, and multidisciplinary collaboration to achieve optimal outcomes. For many patients, valve surgery is a life-extending intervention that also aims to improve everyday functioning and exercise capacity. See Heart valve for a broader overview of the anatomy and function involved.

Historical development

The modern era of valve surgery began with refinements in valve replacement and repair techniques, aided by improvements in anesthesia, imaging, and postoperative care. Early attempts at prosthetic replacement evolved from simple devices to durable mechanical and bioprosthetic valves. The development of cardiopulmonary bypass enabled surgeons to access the heart and perform precise repairs or replacements. In the late 20th and early 21st centuries, the rise of catheter-based and minimally invasive techniques broadened treatment for patients who could not tolerate conventional surgery. See Cardiothoracic surgery for the surgical context and Transcatheter valve interventions as a bridge between open and percutaneous approaches.

Indications and patient selection

Valve disease comes in several forms, with different implications for repair versus replacement and for choice of prosthesis. Decisions are individualized, taking into account age, comorbidities, anatomy, and patient preferences, as well as the presence of symptoms and the expected durability of each option.

Aortic valve disease

Aortic stenosis, a narrowing of the aortic valve, and aortic regurgitation, a leakage around the valve, are common indications for intervention. When feasible, repair is limited for the aortic valve; replacement is more often necessary. Prosthetic valve options include mechanical valves, which tend to last longer but require ongoing anticoagulation, and bioprosthetic valves, which may have limited durability but typically spare patients from long-term blood thinners. See Aortic valve for more detail and Transcatheter aortic valve replacement as a percutaneous alternative in appropriate patients.

Mitral valve disease

Mitral stenosis or regurgitation frequently requires repair or replacement. Valve repair, when technically possible, is generally favored because it preserves native tissue and can reduce long-term complications. When replacement is needed, the choice between mechanical and bioprosthetic valves depends on age, bleeding risk, and lifestyle considerations. See Mitral valve and Mitral regurgitation for related topics. Percutaneous options, such as transcatheter mitral valve repair MitraClip or other devices, provide alternatives for select patients.

Tricuspid and pulmonary valve disease

Tricuspid valve disease often accompanies disease of the left heart valves and may improve after left-sided valve surgery. Repair or replacement of the tricuspid valve is considered in specific scenarios, particularly when there is significant regurgitation or dilation of the right heart. Pulmonary valve disorders are less common but may require intervention in certain congenital or acquired conditions. See Tricuspid regurgitation and Pulmonary valve.

Techniques and procedures

Valve surgery encompasses a spectrum of approaches, chosen based on disease characteristics and patient factors.

Open surgical repair and replacement

  • Open-heart surgery with cardiopulmonary bypass allows direct access to heart valves for repair or replacement.
  • Valve repair aims to preserve native tissue when feasible, potentially reducing the need for long-term anticoagulation and preserving better ventricular function.
  • Valve replacement uses prosthetic valves, either mechanical or bioprosthetic, with differing implications for durability and anticoagulation.

Minimally invasive and robotic approaches

  • Minimally invasive techniques involve smaller chest incisions and may include video-assisted or robotic-assisted methods. These approaches can offer shorter recovery in some patients while achieving comparable outcomes to full sternotomy in experienced hands.
  • Indications, limitations, and surgeon experience play important roles in selecting candidates for these options.

Transcatheter and percutaneous therapies

  • Transcatheter aortic valve replacement Transcatheter Aortic Valve Replacement is used increasingly across risk groups, with ongoing assessment of long-term durability and patient selection criteria.
  • Transcatheter mitral and tricuspid interventions are developing rapidly, including percutaneous repair and replacement devices. See MitraClip and related categories for more details.
  • Percutaneous approaches emphasize less invasiveness and shorter recovery, but require careful evaluation of anatomy and device suitability.

Valve repair techniques and devices

  • For the mitral valve, several repair strategies aim to restore leaflet coaptation and chordal balance, reducing regurgitation while avoiding prosthetic replacement.
  • Valve-sparing techniques, when applicable, seek to maintain native valve mechanics and may be preferred in certain populations.

Pediatric and congenital valve surgery

Outcomes, durability, and risks

Outcomes after valve surgery depend on patient factors, the specific valve involved, and the procedure performed. Durability of prosthetic valves varies by type, age, and lifestyle considerations. Mechanical valves offer longevity but require lifelong anticoagulation in many cases, with associated bleeding risks. Bioprosthetic valves may obviate long-term anticoagulation but can wear out over time, potentially necessitating reintervention.

Complications can include bleeding, infection, stroke, valve dysfunction, and arrhythmias. The risk profile is influenced by the patient’s comorbid conditions, the logistics of care, and the experience of the surgical team. Advances in imaging, anesthesia, and perioperative care have contributed to improved safety and shorter hospital stays over time. See Cardiac surgery and Heart valve for broader context and comparative outcomes.

Controversies and debates

Like many areas in medicine, valve surgery features ongoing debates about best practices and resource allocation. Key topics include:

  • Appropriateness of transcatheter therapies in different risk groups. Proponents emphasize less invasiveness and quicker recovery, while critics raise questions about long-term durability, Stroke risk, and the right selection criteria for younger or lower-risk patients. See Transcatheter valve replacement for various viewpoints and evidence.
  • Durability versus anticoagulation burden. Mechanical valves offer durability but often require lifelong anticoagulation, creating bleeding risks that must be weighed against the potential need for reoperation with bioprosthetic options. See Anticoagulation in the context of valve replacement.
  • Access, affordability, and policy. High-cost devices and procedures raise questions about insurance coverage, patient access, and disparities in care. Policy discussions focus on ensuring evidence-based use of advanced therapies while controlling costs.
  • Training, guidelines, and patient autonomy. As devices and techniques evolve, guidelines balance innovation with proven safety, and patients deserve clear information to participate in shared decision-making. See Clinical guidelines for how recommendations are formed and Patient autonomy for a general treatment decision framework.

See also